Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL
Clinical trial NCT01523977 · COMPLETED
Trial details
- NCT number
- NCT01523977
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2017-01-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.